PortfoliosLab logoPortfoliosLab logo
HIMS vs. META
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HIMS vs. META - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Hims & Hers Health, Inc. (HIMS) and Meta Platforms, Inc. (META). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HIMS achieves a -15.28% return, which is significantly lower than META's -5.54% return.


HIMS

1D
0.00%
1M
0.88%
YTD
-15.28%
6M
-25.79%
1Y
-49.74%
3Y*
45.13%
5Y*
14.51%
10Y*

META

1D
4.24%
1M
2.06%
YTD
-5.54%
6M
-2.44%
1Y
-6.29%
3Y*
32.06%
5Y*
13.70%
10Y*
18.15%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HIMS vs. META - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
HIMS
Hims & Hers Health, Inc.
-15.28%34.28%171.69%38.85%-2.14%-55.14%47.47%1.02%
META
Meta Platforms, Inc.
-5.54%13.09%66.05%194.13%-64.22%23.13%33.09%9.65%

Correlation

The correlation between HIMS and META is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.26

Correlation (3Y)
Calculated over the trailing 3-year period

0.28

Correlation (5Y)
Calculated over the trailing 5-year period

0.35

Correlation (All Time)
Calculated using the full available price history since Sep 16, 2019

0.28

Fundamentals

Market Cap

HIMS:

$6.28B

META:

$1.60T

EPS

HIMS:

-$0.05

META:

$27.47

PS Ratio

HIMS:

2.85

META:

7.45

PB Ratio

HIMS:

14.08

META:

6.55

Total Revenue (TTM)

HIMS:

$2.37B

META:

$214.96B

Gross Profit (TTM)

HIMS:

$1.70B

META:

$176.14B

EBITDA (TTM)

HIMS:

$16.04M

META:

$106.31B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HIMS vs. META — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIMS
HIMS Risk / Return Rank: 2020
Overall Rank
HIMS Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
HIMS Sortino Ratio Rank: 2222
Sortino Ratio Rank
HIMS Omega Ratio Rank: 2222
Omega Ratio Rank
HIMS Calmar Ratio Rank: 1717
Calmar Ratio Rank
HIMS Martin Ratio Rank: 1919
Martin Ratio Rank

META
META Risk / Return Rank: 3232
Overall Rank
META Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
META Sortino Ratio Rank: 2929
Sortino Ratio Rank
META Omega Ratio Rank: 2929
Omega Ratio Rank
META Calmar Ratio Rank: 3434
Calmar Ratio Rank
META Martin Ratio Rank: 3434
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HIMS vs. META - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Hims & Hers Health, Inc. (HIMS) and Meta Platforms, Inc. (META). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HIMSMETADifference
Sharpe ratioReturn per unit of total volatility

-0.34

Sortino ratioReturn per unit of downside risk

-0.34

Omega ratioGain probability vs. loss probability

0.96

1.00

-0.04

Calmar ratioReturn relative to maximum drawdown

-0.64

-0.19

-0.45

Martin ratioReturn relative to average drawdown

-1.06

-0.41

-0.65

HIMS vs. META - Sharpe Ratio Comparison

The current HIMS Sharpe Ratio is -0.52, which is lower than the META Sharpe Ratio of -0.18. The chart below compares the historical Sharpe Ratios of HIMS and META, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


HIMSMETADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.52

-0.18

-0.34

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.18

0.31

-0.14

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.47

Sharpe Ratio (All Time)

Calculated using the full available price history

0.22

0.56

-0.34

Drawdowns

HIMS vs. META - Drawdown Comparison

The maximum HIMS drawdown since its inception was -87.29%, which is greater than META's maximum drawdown of -76.74%. Use the drawdown chart below to compare losses from any high point for HIMS and META.


Loading charts...

Drawdown Indicators


HIMSMETADifference

Max Drawdown

Largest peak-to-trough decline

-87.29%

-76.74%

-10.55%

Max Drawdown (1Y)

Largest decline over 1 year

-78.06%

-33.30%

-44.76%

Max Drawdown (3Y)

Largest decline over 3 years

-78.88%

-34.15%

-44.73%

Max Drawdown (5Y)

Largest decline over 5 years

-79.74%

-76.74%

-3.00%

Max Drawdown (10Y)

Largest decline over 10 years

-76.74%

Current Drawdown

Current decline from peak

-59.98%

-20.96%

-39.02%

Average Drawdown

Average peak-to-trough decline

-43.19%

-15.25%

-27.94%

Ulcer Index

Depth and duration of drawdowns from previous peaks

47.08%

15.47%

+31.61%

Volatility

HIMS vs. META - Volatility Comparison

Hims & Hers Health, Inc. (HIMS) has a higher volatility of 25.84% compared to Meta Platforms, Inc. (META) at 8.84%. This indicates that HIMS's price experiences larger fluctuations and is considered to be riskier than META based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HIMSMETADifference

Volatility (1M)

Calculated over the trailing 1-month period

25.84%

8.84%

+17.00%

Volatility (6M)

Calculated over the trailing 6-month period

66.58%

26.58%

+40.00%

Volatility (1Y)

Calculated over the trailing 1-year period

95.97%

35.23%

+60.74%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

83.37%

43.99%

+39.38%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

77.20%

38.64%

+38.56%

Dividends

HIMS vs. META - Dividend Comparison

HIMS has not paid dividends to shareholders, while META's dividend yield for the trailing twelve months is around 0.34%.


PositionTTM20252024
HIMS
Hims & Hers Health, Inc.
0.00%0.00%0.00%
META
Meta Platforms, Inc.
0.34%0.32%0.34%

Financials

HIMS vs. META - Financials Comparison

This section allows you to compare key financial metrics between Hims & Hers Health, Inc. and Meta Platforms, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00B20.00B30.00B40.00B50.00B60.00B20222023202420252026
608.10M
56.31B
(HIMS) Total Revenue
(META) Total Revenue
Values in USD except per share items

HIMS vs. META - Profitability Comparison

The chart below illustrates the profitability comparison between Hims & Hers Health, Inc. and Meta Platforms, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

65.0%70.0%75.0%80.0%20222023202420252026
65.3%
81.9%
Portfolio components
HIMS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.

META - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported a gross profit of 46.09B and revenue of 56.31B. Therefore, the gross margin over that period was 81.9%.

HIMS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.

META - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported an operating income of 22.87B and revenue of 56.31B, resulting in an operating margin of 40.6%.

HIMS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.

META - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported a net income of 26.77B and revenue of 56.31B, resulting in a net margin of 47.5%.


Frequently Asked Questions


HIMS and META have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HIMS has higher volatility (25.84%) compared to META (8.84%). In terms of maximum drawdown, HIMS dropped -87.29% vs META's -76.74%.

META currently has the higher Sharpe Ratio (-0.18 vs -0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HIMS and META

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer